Video

Patient Profile Presentation: A 65-Year-Old Woman With Metastatic RCC

Author(s):

Kathryn E. Beckermann, MD, PhD,Moshe Ornstein, MD, MA

Mehmet Asim Bilen, MD, presents a profile of a 65-year-old woman with metastatic renal cell carcinoma for discussion.

Newsletter

Stay up to date on the most recent and practice-changing oncology data

Subscribe Now!
Related Videos
Bradley McGregor, MD
Regina Barragan-Carrillo, MD
Kathryn E. Beckermann, MD, PhD
Hedyeh Ebrahimi, MD, MPH
Axel Merseburger, MD, PhD
Laurence Albigès, MD, PhD
Charles B. Nguyen, MD
Toni Choueiri, MD, director, Lank Center for Genitourinary Oncology, co-leader, kidney cancer program, Dana-Farber Cancer Institute; Jerome and Nancy Kohlberg Chair, professor, medicine, Harvard Medical School
Yousef Zakharia, MD
Nazli Dizman, MD
Related Content
RCC | Image Credit: © Crystal light – stock.adobe.com
March 19th 2025

Fruquintinib/Sintilimab Generates Favorable PFS Outcomes in Advanced RCC

Oncology Unplugged With Dr Chandler Park
February 26th 2025

Neoadjuvant MVAC/Pembrolizumab Generates Unprecedented pCR Rates in Non-Urothelial MIBC: With Chandler Park, MD; Petros Grivas, MD, PhD; and Ruben Raychaudhuri, MD

Casdatifan in ccRCC | Image Credit: © Sebastian Kaulitzki – stock.adobe.com
March 12th 2025

Casdatifan Monotherapy Shows Early Efficacy Signals and Tolerable Safety Profile in Pretreated ccRCC

Oncology Unplugged
November 6th 2024

Review Key Genitourinary Cancer Data From the 2024 ESMO Congress With Chandler Park, MD

Cemiplimab Plus Chemotherapy in Advanced/Metastatic Penile Carcinoma | Image Credit: © Katsyarina – stock.adobe.com
March 11th 2025

Cemiplimab Plus Chemotherapy Yields Responses in Advanced/Metastatic Penile Carcinoma

Kidney Cancer | Image Credit: © Sebastian Kaulitzki – stock.adobe.com
March 10th 2025

Latent Viruses in Human Genome Inspire Novel Directions for Kidney Cancer Immunotherapy